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Endocytosis) is the rapid induction of cell fusion by virions in the absence of viral protein
synthesis. The combination of two amino acid mutations in envelope glycoprotein B (gB), one in the
ectodomain and one in the cytoplasmic tail, can confer FFWO activity to wild type herpes simplex virus
(HSV). In this report, we analyzed the entry and cell fusion phenotypes of HSV that contains FFWO gB, with
emphasis on the cellular receptors for HSV, nectin-1, nectin-2 and HVEM. The ability of an HSV strain with
FFWO gB to efﬁciently mediate FFWO via a speciﬁc gD-receptor correlated with its ability to mediate viral
entry by that receptor. A FFWO form of gB was not sufﬁcient to switch the entry of HSV from a pH-
dependent, endocytic pathway to a direct fusion, pH-independent pathway. The conformation of gB with
FFWO activity was not globally altered relative to wild type. However, distinct monoclonal antibodies had
reduced reactivity with FFWO gB, suggesting an altered antigenic structure relative to wild type. FFWO was
blocked by preincubation of virions with neutralizing antibodies to gB or gD. Together with previous studies,
the results indicate that the roles of gB in FFWO and in virus–cell fusion during entry are related but not
identical. This study also suggests that the FFWO function of gB is not a speciﬁc determinant for the selection
of HSV entry pathway and that antigenic differences in FFWO gB may reﬂect its enhanced fusion activity.
© 2008 Elsevier Inc. All rights reserved.IntroductionFusion of herpes simplex virus (HSV) with the host cell during viral
entry is thought to be initiated by interaction of viral envelope
glycoprotein D (gD) with a cognate receptor followed by the
involvement of gB and the gH–gL complex (Atanasiu et al., 2007;
Avitabile et al., 2007; Krummenacher et al., 2007; Spear and
Longnecker, 2003; Subramanian and Geraghty, 2007). Direct study
of the fusion activity of herpesvirions during entry has proven
difﬁcult. Fusion-from-without (FFWO) is cell fusion caused by contact
of virions with the target cell surface at high MOI in the absence of
HSV protein synthesis (Falke et al., 1985). HSV-induced FFWO shares
key features with membrane fusion during viral entry. Both processes
involve the interaction of the viral membrane with the host cell target
membrane and are dependent on the presence of an appropriate gD-
receptor in the target membrane (Delboy et al., 2006). Transfer of gB
from a FFWO strain of HSV into a wild type HSV background confers
FFWO activity, suggesting that gB is a critical determinant of FFWO
activity (Saharkhiz-Langroodi and Holland, 1997).
The structure of an ectodomain fragment of HSV-1 gB reveals an
extended multi-domain architecture (Heldwein et al., 2006). gB has
striking structural similarity to the postfusion form of vesicularoom 6-038, P.O. Box 980678,
946.
l rights reserved.stomatitis virus glycoprotein G (Roche et al., 2006). Both glycoproteins
are members of a new family of fusion proteins, class III (Weissenhorn
et al., 2007). HSV-1 gB has a central, alpha-helical structure (Domain
III; Fig. 4A) that is reminiscent of the coiled coil domains of class I viral
fusion proteins (Earp et al., 2005). The base domain (Domain I; Fig. 4A)
consists of elongated beta sheets interrupted by bipartite hydrophobic
regions that may function as internal fusion loops (Hannah et al.,
2007). An ectodomain and a cytoplasmic tail syncytial mutation in gB
are both needed for FFWO (Saharkhiz-Langroodi and Holland, 1997).
The ectodomain mutation (V553A) maps to Domain III of the gB
structure, which also encompasses the coiled coil. This mutation has
been described as a rate-of-entry determinant (Bzik et al., 1984) and is
shared by the FFWO strains ANG path, HSZP, and HFEM syn.
The HSV-1 strains ANG (Munk and Donner, 1963) and its mouse
brain-passaged derivative, ANG path (Kaerner et al., 1983), have FFWO
activity. Both strains also have unique entry phenotypes. Due to
mutations in the N-terminus of gD (Dean et al., 1995; Izumi and
Stevens, 1990), ANG and ANG path have an enhanced ability to utilize
the nectin-2 receptor for entry (Delboy et al., 2006; Warner et al.,
1998). Wild type HSV strains are readily inhibited by soluble forms of
gD (Johnson et al., 1990; Nicola et al., 1996); however, entry of ANG or
ANG path, is highly resistant to inhibition by either soluble wild type
gD or soluble ANG gD (Nicola et al., 1997).
HSV can utilize endocytic or non-endocytic entry pathways in a
cell-type-dependent manner (Nicola et al., 2003). The process by
which the entry pathway is selected is not clear. Viral determinants,
Table 1
Composition of viruses used in this study
HSV-1 strain Background gB gD FFWO activitya
KOS KOS KOS gB KOS gD −
ANG path ANG path ANG path gB ANG path gD +b
27/III ANG path KOS gB ANG path gD −c
KBang KOS ANG path gB KOS gD +d
a Ability of virions to induce cell fusion of Vero cells in the absence of protein
synthesis.
b Falke et al., 1985.
c Lingen et al., 1995b.
d Saharkhiz-Langroodi and Holland, 1997.
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inﬂuence the entry route taken by HSV (Delboy et al., 2006; Gianni
et al., 2004; Milne et al., 2005; Nicola et al., 2003; Nicola and Straus,
2004; Stiles et al., 2007). The majority of HSV-1 and HSV-2 strains
tested to date enter Chinese hamster ovary (CHO) cells expressing gD-
binding receptors by a pH-dependent, endocytic mechanism (Nicola
et al., 2003). However, ANG path enters CHO-nectin-2 cells by pH-
independent penetration at the cell surface (Delboy et al., 2006). This
led to speculation that FFWO gB, since it has enhanced fusion activity,
might function to override the requirement for endocytosis, and allow
ANG path to fuse directly with the plasma membrane of CHO cells to
accomplish entry.
In this study, we analyzed the functional role of speciﬁc receptors
in the entry and FFWO activities of recombinant viruses that contain
chimeric gB. We also used monoclonal antibodies (MAbs) to probe the
antigenic conformation of FFWO gB, and assessed the ability of gB-Fig. 1. Entry of chimeric strains of HSV into CHO cells mediated by nectin-1, nectin-2, or HVEM
(B), CHO-nectin-2 cells (C), or CHO-HVEM cells (D) at MOIs ranging from 0 to 10. Beta-galacto
entry. Data are means of quadruplicate determinations. Maximal values in B, C, and D correspeciﬁc MAbs to neutralize infection by FFWO strains of HSV. Together
with previous studies, the results indicate that the roles of gB in FFWO
and in virus–cell fusion during entry are related but not identical.
Results
Utilization of entry receptors nectin-1, nectin-2 or HVEM by HSV that
contains gB with FFWO activity
Current models of HSV entry propose that after the binding of
virion gD to one of its cognate receptors, gD interacts laterally with gB
and gH–gL to trigger membrane fusion and penetration (Atanasiu et
al., 2007; Avitabile et al., 2007; Krummenacher et al., 2007; Perez-
Romero et al., 2005; Spear and Longnecker, 2003; Subramanian and
Geraghty, 2007). We ﬁrst examined the receptor usage of HSVs that
contain FFWO forms of gB (Table 1). For these studies, we used the
HSV-1 FFWO strain ANG path, its parent, ANG, and the non-FFWO,
wild type strain KOS. To evaluate speciﬁcally the role of gB, we
employed HSV-1 27/III which has an ANG path background but has
KOS gB in place of ANG path gB (Lingen et al., 1995b) (Table 1), and
HSV-1 KBang which has KOS background with ANG path gB in place of
KOS gB (Saharkhiz-Langroodi and Holland, 1997) (Table 1). KBang
mediates FFWO of Vero cells (Saharkhiz-Langroodi and Holland, 1997)
but 27/III does not (Lingen et al., 1995b) (Table 1).
To determine the efﬁciency of receptor utilization by the panel of
viruses, we measured entry into receptor-negative CHO cells and into
CHO cells expressing nectin-1, nectin-2, or HVEM (Fig. 1). HSV-
induced expression of beta-galactosidase was as an indicator of
successful viral entry. In control experiments, we conﬁrmed the role of. The indicated strain of HSV-1 was added towild type CHO cells (A), CHO-nectin-1 cells
sidase activity of cell lysates was quantiﬁed at 6 h post-infection as an indication of viral
spond to 100% of cells infected.
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1998; Montgomery et al., 1996; Warner et al., 1998). We also
conﬁrmed our previous ANG path results with nectin-1 and nectin-2
(Delboy et al., 2006).
The HSV chimera KBang entered wild type CHO cells with low
efﬁciency (Fig. 1A). Interestingly, this ability is shared with KOS (Shieh
et al., 1992) but not with viruses that have FFWO gB (Fig. 1A). This
result suggests that a non-gB component of the KOS background
allows utilization of an endogenous hamster receptor. 27/III, like ANG
path and ANG, entered CHO-nectin-1 cells ∼1 log less efﬁciently than
wild type KOS (Fig. 1B). The data also suggest that the majority of cells
are not susceptible to infection by these viruses, even at high MOI.Fig. 2. The pH-dependence of gD-receptor-mediated entry of HSV chimeras. CHO cells e
concentrations of monensin (left) or ammonium chloride (NH4Cl; right) for 15 min. Except
presence of inhibitor. Similar results were obtained at an MOI of 10 (data not shown). Entr
absence of lysosomotropic agent. Data are means of quadruplicate determinations with staKBang utilized nectin-1 with wild type efﬁciency (Fig. 1B). The results
are consistent with reports that nectin-1 interacts to a greater extent
with KOS gD than with gD containing N-terminal mutations, such as
ANG and ANG path gDs (Delboy et al., 2006; Krummenacher et al.,
1998, 2004).
HSV-1 27/III and ANG path entered CHO-nectin-2 cells efﬁciently
due to the ANG path gD allele (Fig. 1C). A similar result was obtained
with ANG (Fig. 1C). To a lesser degree, the presence of nectin-2
enhanced KBang and KOS entry above the CHO cell background (Figs.
1C and A), consistent with reports that KOS gD does not effectively
engage nectin-2 in CHO cells (Delboy et al., 2006; Warner et al., 1998).
KOS and KBang which both contain wild type KOS gD, entered CHO-xpressing nectin-1 (A), nectin-2 (B), or HVEM (C) were treated with the indicated
where indicated in the text, virus was added at an MOI of 1 for 6 h in the continued
y was measured as the % of beta-galactosidase activity relative to that obtained in the
ndard error.
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supported only residual entry of 27/III, ANG path and ANG, each of
which bear N-terminal mutations in gD (Fig. 1D). As expected, the
form of gD present in the virus determined receptor usage. The
presence of FFWO gB in the viral envelope did not alter gD-receptor
utilization by HSV.Fig. 3. Receptor-mediated fusion-from-without activity of chimeric strains of HSV. ANG path
or CHO cells expressing either nectin-1 (F–J, U–V), nectin-2 (K–O), or HVEM (P–T) in the pres
with methanol and stained with Giemsa. Magniﬁcation, 4×. (W) Fusion-from-without was q
standard deviation are shown. nd, not determined.Entry pathway utilization by HSV that contains FFWO gB
With the exception of ANG path (Delboy et al., 2006), all HSV
strains tested to date enter CHO-receptor cells by a low pH, endocytic
pathway (Nicola et al., 2003). ANG path entry into CHO-nectin-2 cells
is refractory to inhibitors of endocytosis and endosomal acidiﬁcationvirions (MOI of 50 except where noted) were added to receptor-negative CHO cells (A–E)
ence of 1 mM cycloheximide. Cells were incubated at 37 °C for 3 h, and were then ﬁxed
uantiﬁed as indicated in Materials and methods. Means of triplicate determinations and
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possibility that ANG path gB might be a determinant for directing
entry by a pH-independent pathway. The receptor-expressing CHO
cells were treated with monensin or ammonium chloride, which
elevate endosomal pH. For all viruses tested, entry into CHO-nectin-1
cells was inhibited in a concentration-dependent manner (Fig. 2A),
indicating a pH-dependent entry mechanism mediated by nectin-1
regardless of whether the FFWO allele of gB was present in the virion.
27/III entry was the least sensitive to monensin but the most sensitive
to ammonium chloride, suggesting that something in addition to pH
may be altered by one or both agents.
Entry of 27/III into CHO-nectin-2 cells was partially resistant to
inhibition by lysosomotropic compounds in a manner similar to ANG
path (Fig. 2B). Because 27/III contains wild type KOS gB, the unique
mode of entry of ANG path into CHO-nectin-2 cells cannot be
explained by FFWO gB alone. Another viral component of ANG path
likely determines the pH-independent entry phenotype. Entry of the
parental strain ANG into CHO-nectin-2 cells was also resistant to
inhibition by monensin and ammonium chloride (Fig. 2B). This
indicates that pH-independent entry activity was not acquired from
passage of ANG in mouse brain but was present initially in ANG. Entry
of KBang and wild type HSV-1 strain KOS into CHO-nectin-2 cells was
tested at an MOI of 10, and was inhibited by the pH-altering agents
(Fig. 2B). As an additional control, HSV-1 rid1 entry into CHO-nectin-2
at an MOI of 1 or 10 was effectively inhibited by ammonium chloride
and monensin (Delboy et al., 2006) (data not shown). Entry of KBang,Fig. 4. Antigenic reactivity of HSV-1 ANG path gB. (A) The protein backbone of a gB monom
activity of HSV-1 ANG path (V553A) is denoted in CPK representation (pink). Other HSV-1
confers resistance to neutralization by MAb H126 is indicated. This residue is contained wit
(DeLano, 2002) and domains assigned after (Heldwein et al., 2006). (B) Detection of gB trime
denaturing SDS-PAGE (right) followed by Western blot with gB-speciﬁc polyclonal antiserum
(C–F) Dot blot analysis of virion gB. Serial, two-fold dilutions of ∼5×105 PFU (left to right) of H
gB was detected by the primary antibody (C) DL16, (D) H126, (E) R69 or (F) SS55 followed
exposed to ﬁlm. (G) HSV-1 KOS or ANG path was subjected to denaturing SDS-PAGE followwhich has the ANG path gB allele and efﬁciently enters CHO-HVEM
cells (Fig. 1D), was inhibited by lysosomotropic agents in a manner
similar to wild type (Fig. 2C). Together, the data suggest that FFWO
activity of gB is not sufﬁcient to trigger direct, pH-independent entry
at the cell surface.
Receptor-speciﬁc fusion-from-without activity
We tested the ability of the panel of viruses to trigger FFWO
mediated by nectin-1, nectin-2, or HVEM. None of the viruses tested
induced FFWO on the receptor-negative CHO cells (Figs. 3A–E), even at
an MOI of 1000 (not shown). As expected, 27/III and KOS, which have
wild type gB, did not trigger FFWO on any of the gD-receptor-bearing
cells (Figs. 3F, G, K, L, P, and Q). Both ANG path and ANG caused FFWO
on CHO-nectin-2 cells (Figs. 3M–N). These two viruses caused no
demonstrable FFWO on CHO-nectin-1 cells (Figs. 3H–I). However,
when ANG path or ANGwere added to CHO-nectin-1 cells at anMOI of
1000, FFWO was detected (Figs. 3U–V). Thus, FFWO correlated with
how efﬁciently nectin-1 and nectin-2 receptors were utilized by ANG
and ANG path for entry (Figs. 1B–C). HSV-1 strain KBang mediated
FFWO of both CHO-nectin-1 and CHO-HVEM cells (Figs. 3J and T),
owing to the presence of KOS gD and ANG path gB in the virion. We
can conclude that HVEM receptors, like nectin-1 and nectin-2 (Delboy
et al., 2006), are capable of triggering FFWO. Addition of KBang to
CHO-nectin-2 cells caused no detectable FFWO (Fig. 3O). Quantiﬁca-
tion of clusters of nuclei as an indicator of FFWO (Fig. 3W) correlateder is shown in ribbon designation. The ectodomain mutation that is required for FFWO
FFWO strains also have an alanine at this position. A mutation at aa position 303 that
hin the linear epitope recognized by H126. Ribbon structure was prepared with PyMOL
rs in ANG path virions. HSV-1 KOS or ANG path was subjected to “native” PAGE (left) or
. gB trimers or monomers and molecular weight markers in kilodaltons are indicated.
SV-1 KOS or ANG path in PBS were blotted directly to nitrocellulose membranes. Virion
by HRP-conjugated secondary antibody. Blots were developed with ECL reagents and
ed by Western blot with antibodies R69, H1817, or H126.
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previous work, these results underscore the importance of ANG
path gB for receptor-mediated FFWO. For FFWO strains of HSV, a
receptor's ability to trigger FFWO (Fig. 3) correlated with its ability to
mediate entry (Fig. 1).
Antigenic analysis of gB with FFWO activity
The presence of ANG path gB is sufﬁcient to confer nectin-1-
mediated and HVEM-mediated FFWO activity to KOS virions (Figs. 3J
and T). To address whether changes in the antigenic structure of ANG
path gB correlate with enhanced fusogenic activity, we characterized
the reactivity of ANG path virions with a panel of MAbs to gB. The
mature ANG path gB has 9 amino acid changes relative to KOS gB
(Saharkhiz-Langroodi and Holland, 1997). Previous studies have
indicated that both a A855V syncytial mutation in the cytoplasmic
tail of gB (Lingen et al., 1995b) and a V553A mutation in the
ectodomain (Saharkhiz-Langroodi and Holland, 1997) are required for
ANG path FFWO activity. Domain III of gB contains a central, alpha-
helical coiled coil domain (Fig. 4A; Heldwein et al., 2006). This is a
common structural feature of many viral fusion proteins (Earp et al.,
2005). The FFWO ectodomain mutation maps to Domain III, near the
coiled coil (Fig. 4A).
The oligomeric structure of gB is disrupted by heat and high
concentrations of SDS (Claesson-Welsh and Spear, 1986) (Fig. 4B).
Thus, gB oligomers can be visualized by “native” PAGE analysis when
samples contain 0.2% SDS and are unheated (Bender et al., 2007;
Cohen et al., 1986). The oligomeric form resolved under “native”
conditions was revealed by the crystal structure to be a trimer
(Heldwein et al., 2006). After “native” PAGE, oligomers of gB were
detected in both ANG path and KOS virions by a polyclonal antibody to
gB (Fig. 4B), suggesting that gB with FFWO activity exists as a trimer.
We compared the antigenic reactivity of ANG path gB and KOS gB
by directly blotting virions to nitrocellulose membranes and testing a
panel of MAbs. Seven of nine antibodies tested displayed equivalent
reactivity with gB from both viruses (Figs. 4E and F, Table 2). These
MAbs detect both conformation-dependent and conformation-
independent epitopes of gB (Bender et al., 2007), suggesting that
FFWO gB is not globally altered with respect to wild type.
MAb DL16 had signiﬁcantly reduced reactivity with ANG path
virions relative to wild type KOS virions (Fig. 4C). DL16 is conforma-
tion-dependent and speciﬁc for the oligomeric form of gB (Bender et
al., 2005), but speciﬁc residues of its epitope are not known. DL16 also
had reduced reactivity against gB from FFWO strains ANG, KBang,
HSZP and HFEM syn (not shown). Reduced binding of DL16 may be
due to altered conformation of the gB trimer of ANG path. Whether
one or more amino acid changes in ANG path gB contributes to DL16
binding remains to be determined.Table 2
Reactivity and neutralization activity of gB-speciﬁc antibodies
Reactivitya Neutralizationb
Vero HaCaT
MAb Notes KOS ANG path KOS ANG path KOS ANG path
DL16 Trimer-speciﬁc + weak − − nd nd
DL21 Not grouped + + − − − −
H126 Domain I + − + + + +
H1817 Domain VI + + nd nd nd nd
SS10 Domain IV + + + + + +
SS55 Domain I + + + + + +
SS106 Domain V + + − − nd nd
SS118 Domain I + + − − − −
SS144 Domain V + + + + + +
nd, not determined.
a Measured via “native” Western blot or dot blot.
b +, N50% plaque reduction at MAb dilution bor =0.002; −, b50% plaque reduction.MAb H126 recognizes a linear epitope in Domain I of gB (Fig. 4A)
(Heldwein et al., 2006; Kousoulas et al., 1984). Domain I amino acid
303 is mutated in an HSV mutant that is resistant to neutralization by
MAb H126 (Kousoulas et al., 1988). Here we show that H126
recognized KOS gB after analysis of virions by non-denaturing
approaches including dot blot, “native” PAGE, and immunoprecipita-
tion (Fig 4D, Table 2, and not shown). Notably, H126 had greatly
reduced reactivity with ANG path gB by these same measures.
Additional FFWO strains of HSV including ANG, KBang, HSZP, and
HFEM syn (Chapsal and Pereira, 1988) had similarly reduced reactivity
with H126 (data not shown). Importantly, when ANG path virions
were analyzed by denaturing SDS-PAGE, H126 and two control
antibodies did detect ANG path gB (Fig. 4G). The results indicate
that the peptide sequence to which H126 binds is present in ANG path
gB, but it may have altered accessibility. For example, the H126
epitope may be buried in the native, trimeric structure of ANG path gB
but exposed on the surface of wild type gB. In total, the analysis
suggests that ANG path gB has detectable differences in antigenic
structure relative to wild type.
HSV-1 ANG path has unaltered sensitivity to neutralization by
gB-speciﬁc monoclonal antibodies, including H126
An antibody that neutralizes virus infection in the absence of
complement is directed against an epitope that is important for
function.MAbs speciﬁc for gBwere tested for their ability to neutralize
HSV-1 ANG path. The dilution of antibody required to reduce plaque
numbers by 50% was determined. Since CHO-receptor cells do not
support plaque formation of HSV, Vero and HaCaT cells were utilized.
Table 2 shows that ANG path was sensitive to neutralization by MAbs
H126, SS10, SS55, and SS144. In contrast, potent neutralization of ANG
path was not detected by MAbs DL16, DL21, SS106, and SS118 at the
dilutions tested. Each of the antibodies neutralized HSV-1 KOS to a
similar extent. Thus, despite its unique function, ANG path gB does not
appear to be globally altered in structure relative to wild type. Our
results with MAb neutralization of KOS (Table 2) were consistent with
previous ﬁndings (Bender et al., 2005, 2007; Kousoulas et al., 1984),
with the exception of SS106 and SS118, which did not effectively
neutralize HSV in our experiments. This discrepancymay be explained
by the use of ascites ﬂuid instead of IgG or by different criteria for
neutralization.
MAb H126 effectively neutralized ANG path infection (Table 2)
despite its signiﬁcantly reduced reactivity with native ANG path gB
(Fig. 4D and Table 2). This may be explained by increased exposure of
the H126 epitope during ANG path entry. Nonetheless, these results
are consistent with the presence of the H126-binding sequence in
ANG path gB (Fig. 4G).
HSV gB, along with gD, and gH–gL, is required for successful entry
via either the endocytosis pathway or by direct penetration at the
plasma membrane (Cai et al., 1988; Nicola and Straus, 2004; Spear,
1993). Vero cells support HSV entry by pH-independent fusion with
the plasma membrane, and HaCaT cells support entry via a pH-
dependent, endocytic mechanism (Nicola et al., 2003, 2005; Wittels
and Spear, 1991). All of the MAbs to gB tested exhibited similar
neutralization activity whether assayed on Vero or HaCaT cells (Table
2). Within the limits of these experiments, a difference in the
functional role of gB in these two entry pathways was not detected.
Antibodies to gB or gD block fusion-from-without
Neutralizing antibodies speciﬁc for gB or gD can block virus entry
at receptor-binding and/or fusion steps during viral entry (Bender et
al., 2005; Fuller and Spear, 1987; Highlander et al., 1987, 1988;
Muggeridge et al., 1990; Nicola et al., 1998; Pereira, 1994). Antibodies
to gD and gB also inhibit fusion of infected cells as measured by
syncytium formation (or fusion-from-within) (Navarro et al., 1992;
Fig. 5. Inhibition of FFWO by glycoprotein-speciﬁc antibodies. Six micrograms/milliliter
of mouse monoclonal antibody to gB (H126, H1817, or H1359), to gD (1103), or to Golgi
protein p58 was mixed with HSV-1 ANG path for 1 h at 37 °C. Virus–antibody mixtures
were added to Vero cells (MOI of 50) for 3 h, and FFWOwas detected and quantitated as
in Fig. 3.
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monoclonal antibodies has not been tested. ANG path virions were
preincubated withMAb and then added to Vero cells. TwoMAbs to gB,
H126 and H1817, both effectively blocked FFWO (Fig. 5). H126
inhibited ANG path virion-induced fusion (Fig. 5), even though this
epitope appears to be presented differently in ANG path gB (Fig. 4 and
Table 2). MAb H1359, which recognizes gB but is non-neutralizing
failed to block ANG path-induced FFWO, suggesting that only speciﬁc
regions of gB are involved in FFWO. The gD-speciﬁc, neutralizing MAb
1103 blocked FFWO (Fig. 5). As an additional control, the heterologous
mouse MAb to the Golgi protein p58 had no effect on FFWO (Fig. 5).
These results underscore the importance of functional regions on gB
and gD for HSV membrane fusion as measured by FFWO.
Discussion
Although HSV gB is required for membrane fusion (Cai et al., 1988;
Hannah et al., 2007; Heldwein et al., 2006; Highlander et al., 1988;
Navarro et al., 1992; Pereira, 1994; Saharkhiz-Langroodi and Holland,
1997; Turner et al., 1998), the exact nature of its role remains to be
elucidated. In the absence of a means to directly study virion–cell
fusion during viral entry, we used FFWO as a surrogate to learn more
about this process. In this report, we show that relationships between
gD and receptor use during FFWO are the same as those during virus
entry. FFWO activity of gB is not sufﬁcient to trigger virus entry by
fusion of the viral envelope with the plasma membrane. Therefore, an
additional property of ANG path must enable it to enter CHO-nectin-2
cells by this pH-independent pathway. Antigenic analysis suggests
that FFWO gB is conformationally distinct relative to wild type.
Altered arrangement of the putative fusion domain in ANG path gB
may account for its enhanced fusogenicity and the pH-independence
of FFWO.
HSV gD is the viral ligand for HVEM and nectin receptors
(Krummenacher et al., 2007; Spear and Longnecker, 2003). PILRalpha
was recently reported as a receptor for gB (Satoh et al., 2008). Despite
several distinct phenotypes associated with the entry of FFWO strains
(Delboy et al., 2006; Lingen et al., 1995a; Montgomery et al., 1996;
Nicola et al., 1997; Warner et al., 1998), the presence of FFWO gB in a
given virus had no bearing on which gD-receptor was utilized for
entry. As expected, the allele of gD present in the virion determined
the utilization of nectin-1, nectin-2, or HVEM.
Unlike themajority of HSV-1 and HSV-2 strains tested (Nicola et al.,
2003), ANG path can enter receptor-expressing CHO cells in a pH-
independent manner (Delboy et al., 2006). Since ANG path gB isresponsible for the enhanced fusogenicity associated with FFWO
(Saharkhiz-Langroodi and Holland, 1997), we speculated that ANG
path gB might allow HSV to enter by fusing directly with the plasma
membrane, obviating the need for endocytosis. However, this was not
the case in themodel system under study (Fig. 2B). A non-gBmutation
in theANGpath backbone likelyaffects the pH-dependence of entry. Of
the three receptors tested, only nectin-2 supported pH-independent
entry of ANG path-related strains into CHO cells. gD is the viral ligand
for nectin-2 (Warner et al., 1998), and the three viruses that entered
CHO-nectin-2 cells by a pH-independent pathway all contain ANG gD
or ANG path gD. Thus, it may be the combination of this gD-nectin
interaction at the surface of CHO-nectin-2 cells that triggers direct
fusionwith the plasmamembrane during viral entry. Another possible
determinant is the ANG path gH–gL complex about which little is
known. These possibilities need to be tested directly.
This report highlights further similarities between FFWO and
virus–cell fusion during entry. Like virus entry, FFWO requires an
appropriate gD-receptor in the target membrane (Delboy et al.,
2006). Here we show that HVEM, as well as nectin-1 and nectin-2, is
capable of triggering FFWO provided that the correct partner gD is
present in the virus. For any of the FFWO-inducing strains tested, if a
receptor was capable of mediating entry into CHO cells, it was also
capable of mediating FFWO. Further, the efﬁciency of receptor usage
for entry correlated with the efﬁciency of receptor usage for FFWO.
Antibodies to gB and gD that neutralize virus entry also blocked
FFWO.
Nectin-1 and HVEM both trigger pH-independent FFWO of CHO
cells, yet entry into CHO cells mediated by these receptors occurs after
endocytosis and is pH-dependent. Addition of CHO cells that express
gB, gD, and gH–gL to target CHO cells also results in pH-independent
cell fusion (Pertel et al., 2001). Both FFWO and cell–cell fusion share
the CHO cell surface as the target membrane for fusion. Virions that
mediate FFWO with the plasma membrane may not necessarily
initiate successful infection, i.e., incoming nucleocapsids may not be
properly directed to the nucleus. Thus, pH-dependent fusion of HSV
with the endosomal membrane during viral entry may be the most
physiologically relevant fusion mechanism for CHO cells because it
results in infection. Nonetheless, these apparent incongruities may be
explained by the ability of HSV glycoproteins to mediate both pH-
independent and pH-dependent fusion mechanisms (Nicola et al.,
2003; Nicola and Straus, 2004).
We show that ANG path gB, like KOS gB, is trimeric (Fig. 4B).
However, ANG path gB (Fig. 4C) and gB from other FFWO strains (data
not shown) have reduced reactivity with the trimer-speciﬁc MAb
DL16. Oligomeric rearrangements in viral glycoproteins can accom-
pany membrane fusion activity (Allison et al., 1995; Wahlberg and
Garoff, 1992). DL16 may detect a difference in the arrangement of the
quaternary structure of wild type and FFWO gBs.
A linear stretch of amino acids in Domain I of ANG path gB is
recognized by MAb H126. However, in the native structure of ANG
path gB, this region has altered accessibility to H126 as measured by
dot blot or “native” Western blot. MAbs SS55 and SS118 recognize
Domain I of ANG path and KOS gBs to a similar extent, arguing
against a dramatic change in the structure of Domain I. Surprisingly,
H126 neutralizes ANG path and inhibits FFWO. This discrepancy
may be explained by an unknown artifact in the blotting assays.
Alternately, the H126 epitope may undergo increased exposure
during the processes of entry and FFWO. H126 neutralizes endocytic
entry of ANG path into HaCaT cells and non-endocytic entry into
Vero cells suggesting that such a change in the conformation of gB
may occur just after binding to the cell surface or just prior to
fusion.
Domain I of gB is important for function (Bender et al., 2007;
Highlander et al., 1989; Lin and Spear, 2007; Pellett et al., 1985; Pereira
et al., 1989) and is the putative fusion domain (Hannah et al., 2007).
The reduced recognition of FFWO strains by H126 is not readily
214 D.G. Roller et al. / Virology 382 (2008) 207–216explained by differences in gB amino acid sequences relative to wild
type. We favor the interpretation that altered antigenic reactivity is
due to a distinct conformation of FFWO gB relative to wild type. The
relative orientation of Domain I of FFWO gB may alter accessibility of
the H126 epitope on the trimeric structure. Interestingly, the
analogous fusion domain of VSV G is arranged differently in the
prefusion and postfusion forms, while its structure remains unaltered
(Roche et al., 2006, 2007). We propose that a change in the orientation




Vero cells (American Type Culture Collection; ATCC; Rockville, Md.)
and HaCaT cells (obtained from Harvey Friedman, University of
Pennsylvania) were propagated in Dulbecco's Modiﬁed Eagle's
Medium (Invitrogen, Grand Island, NY) supplemented with 10% fetal
bovine serum (FBS; Gemini Bio-Products, West Sacramento, Calif.).
Chinese hamster ovary (CHO)-K1 cells stably transformed with the
Escherichia coli lacZ gene under the control of the HSV ICP4 promoter
(CHO-IEβ8 cells) (Montgomery et al., 1996). CHO-IEβ8 cells stably
transformed to express the human gD-receptors nectin-1, nectin-2, or
HVEM (Geraghty et al., 1998; Nicola et al., 1998; Warner et al., 1998)
(obtained from Gary Cohen and Roselyn Eisenberg, University of
Pennsylvania) were propagated in Ham's F12 nutrient mixture
(Invitrogen) supplemented with 10% FBS, 150 mg/ml puromycin
(Sigma, St. Louis, Mo.), and 250 mg/ml G418 sulfate (Fisher Scientiﬁc,
Fair Lawn, NJ). Cells were subcultured in non-selective medium prior
to use in experiments.
HSV-1 strains KOS, ANG path (Kaerner et al., 1983), and KBang
(Saharkhiz-Langroodi and Holland, 1997) were obtained from Thomas
Holland, Wayne State University. HSV-1 strain ANG (Munk and
Donner, 1963) was obtained from R. Eisenberg and G. Cohen. HSV-1
strains 27/III (Lingen et al., 1995b) and HSZP were obtained from
Dietrich Falke, University of Mainz. All viruses were propagated and
titered on Vero cells.
Chemicals
Stocks of 0.5M cycloheximide (Sigma) andmonensin (Sigma)were
prepared in ethanol and stored at −20 °C.1.5 M ammonium chloride (J.
T. Baker) was prepared fresh in distilled water.
Antibodies
Mousemonoclonal antibodies (MAbs) to gB designated DL16, DL21,
SS10, SS48, SS55, SS106, SS118, and SS144 (Bender et al., 2005, 2007;
Heldwein et al., 2006) were kindly provided by R. Eisenberg and G.
Cohen. MAbs H126, H1817, and H1359 (all from Virusys) are also
speciﬁc for gB. MAb 1103 (Goodwin Institute, Plantation, FL) is speciﬁc
for gD.
Beta-galactosidase reporter assay for HSV entry
Conﬂuent cell monolayers grown in 96 well dishes were treated
with medium containing lysosomotropic compounds or vehicle
controls for 30 min at 37 °C. HSV was added, and cells were incubated
in the constant presence of agent for 6 h. 0.5% Nonidet P-40 (Sigma)
cell lysates were prepared, chlorophenol red-beta-D-galactopyrano-
side (Roche Diagnostic, Indianapolis, In.) was added, and beta-
galactosidase activity was read at 595 nm with an ELx808 microtiter
plate reader (BioTek Instruments, Winooski, Vt.). Beta-galactosidase
activity indicated successful entry. Mean results and standard error
were calculated for four replicate samples.Treatments with lysosomotropic agents
Stock solutions of ammonium chloride (1.5 M) were prepared
immediately prior to use. Monensin (75 mM; Sigma) stock solutions
were prepared in ethanol and stored at −20 °C. Growth medium was
removed from cells and replaced with medium containing agents or
medium containing control concentrations of ethanol, and the
mixture was incubated for 30 min at 37 °C. Virus was added, and
cells were incubated in the constant presence of agent for the length of
the beta-galactosidase reporter assay. Treatments had no effect on cell
viability as measured by trypan blue exclusion.
Plaque assay
At 18–24 h p.i., culture mediumwas removed, and cells were ﬁxed
with ice-cold methanol-acetone solution (2:1 ratio) for 20 min at
−20 °C and air-dried. Virus titers were determined by immunoperox-
idase staining with anti-HSV polyclonal antibody HR50 (Fitzgerald
Industries, Concord, Mass.).
Fusion-from-without assay
As described previously (Delboy et al., 2006; 2008), Vero cells were
pretreated with growth medium containing 0.5 mM cycloheximide.
Cell-free supernatant preparations of HSV-1 ANG path were added to
cells (MOI of 50) for 3 h at 37 °C in the constant presence of
cycloheximide. Cells were rinsed with PBS, and then ﬁxed in 100%
methanol. Monolayers were air-dried, and then nuclei were stained
with Giemsa.
Micrographs were taken with a Zeiss Axiovert 40C microscope
equipped with a Canon PowerShot G6 digital camera. Digital images
were processed with Adobe Photoshop CS2 version 9.0. To quantitate
fusion, photomicrographs of random ﬁelds from triplicate wells (N500
cells/well) were scored. The number of nuclei present in clusters of 4
or more divided by the total number of nuclei yielded the % fusion.
This is a means of quantitation but is an underestimate of total
number of fusion events. Less than 1% FFWO was obtained in the
absence of virus.
Dot blot analysis of virion gB
Cell-free supernatants of HSV-infected Vero cells were diluted in
PBS and blotted directly to nitrocellulose with a Mini Fold dot blot
system (Whatman). Strips of membrane were blocked and incubated
with antibody to gB. After incubation with horseradish peroxidase-
conjugated secondary antibodies, enhanced chemiluminescent sub-
strate (Pierce)was added, and blotswere exposed to X-ray ﬁlm (Kodak).
SDS-PAGE and Western blotting
Cell-free supernatants of HSV-infected Vero cells were mixed with
polyacrylamide gel electrophoresis (PAGE) sample buffer containing
either no reducing agent and 0.2% sodium dodecyl sulfate (SDS)
(“native” conditions) or with 200 mM dithiothreitol and 2% SDS
(“denaturing” conditions). Denatured samples were boiled for 5 min
at 100 °C. Proteins were resolved by PAGE. After transfer to
nitrocellulose, membranes were blocked and incubated with antibody
to gB. After incubation with horseradish peroxidase-conjugated
secondary antibodies, enhanced chemiluminescent substrate (Pierce)
was added and membranes were exposed to X-ray ﬁlm (Kodak).
Neutralization assay
Serial dilutions of MAbs were mixed with 100 PFU HSV-1 KOS or
ANG path in DMEM supplemented with heat inactivated fetal bovine
serum. TheMAb-virusmixture was incubated at 37 °C for 1 h and then
215D.G. Roller et al. / Virology 382 (2008) 207–216added to conﬂuent monolayers of Vero or HaCaT cells in 24-well
plates. At 1 h p.i., inoculumwas removed and replaced with DMEM. At
18-24 h p.i., plaque formation of triplicate samples was determined by
immunoperoxidase staining. Neutralization titer wasmeasured as 50%
plaque reduction.
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